Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion type Assertion NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_head.
- NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion description "[Taken together, these studies suggest that activating mutations in ESR1 are a key mechanism in acquired endocrine resistance in breast cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_provenance.
- NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion evidence source_evidence_literature NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_provenance.
- NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion SIO_000772 24185510 NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_provenance.
- NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion wasDerivedFrom befree-2016 NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_provenance.
- NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_assertion wasGeneratedBy ECO_0000203 NP1124535.RAte_tbS1PEtiAAEC2dx_tL_7mKgLSGfQf5lMQ08hIu3A130_provenance.